Today: 29 April 2026
Fortinet stock rises in premarket after earnings beat and upbeat 2026 outlook
6 February 2026
1 min read

Fortinet stock rises in premarket after earnings beat and upbeat 2026 outlook

New York, Feb 6, 2026, 07:00 EST — Premarket

  • Fortinet shares were up in premarket trading following quarterly results that beat forecasts.
  • Traders are focusing on billings to gauge demand in cybersecurity spending.
  • Wall Street is balancing upbeat guidance with ongoing doubts about the strength of services momentum.

Fortinet, Inc (FTNT) shares jumped 2.8% to $81.11 in premarket trading Friday, following a quarterly beat and stronger guidance, despite recent weakness in tech stocks. The cybersecurity company posted adjusted earnings of 81 cents per share and revenue of $1.91 billion, with billings rising to $2.37 billion. It also forecast first-quarter earnings between 59 and 63 cents per share.

The report matters because security software is expected to be the “must-have” budget item when funds tighten — and investors have been putting that belief to the test. A strong beat on billings can quickly ease concerns. A stumble, however, can ripple through the sector.

Fortinet started its earnings report under pressure, slipping 2.7% Thursday to settle at $78.93. Trading volume surged, more than twice the usual average, even as competitors made bigger moves.

Billings don’t equal revenue. They track the value of signed contracts and are closely watched in cybersecurity as an early indicator of upcoming growth, even before it appears in reported sales.

Fortinet’s earnings came in strong, sending its shares up over 4% in after-hours to roughly $82.25. Yet the report also highlighted a weak spot: service revenue, the more predictable subscription and support segment, has once again fallen short.

Investors seek consistency in that service line. It usually evens out the more volatile hardware cycle and often delivers higher margins. When it falters, questions arise about whether deal quality is slipping or if renewals are becoming more challenging.

Initial analyst response to the billings report was upbeat. Jefferies lifted its price target to $90 from $80 but maintained a Hold rating, citing better-than-anticipated billings and product momentum. The firm did caution, however, that the 2026 services forecast might remain challenging.

But there’s a snag. Fortinet’s first-quarter earnings forecast falls short of some Wall Street estimates, and a volatile tech sector could overshadow strong company results once regular trading kicks off.

Competition remains unpredictable. Major rivals continue to pile into the “single platform” approach — combining firewalls, cloud controls, and remote-access security — and prices can shift fast when clients come up for renewal.

Fortinet handed investors more flexibility with cash, announcing its board approved a $1.0 billion boost to the share repurchase program, pushing the total authorization up to $10.25 billion through Feb. 28, 2027. As of Feb. 4, roughly $1.38 billion remained unused. CEO Ken Xie highlighted that the quarter “drove billings above the high end of our guidance.” Traders will be watching management’s upcoming appearances at the Bernstein TMT Forum on Feb. 26 and the Morgan Stanley Technology, Media & Telecom Conference on March 3 for any updates on service momentum. fortinet.com

Stock Market Today

  • Tuya (TUYA) Stock Analysis: Fair Pricing Amid Recent Pullback and Strong Long-Term Gains
    April 29, 2026, 12:05 PM EDT. Tuya (NYSE:TUYA) shares closed at $2.28, down 3.0% in one day and 6.2% over seven days, contrasting with a 3-year total shareholder return of 28.7%. The company reported $321.8 million in annual revenue and $57.9 million net income. Trading at a price-to-earnings (P/E) ratio of 24.1x, Tuya's valuation is slightly above its fair value estimate of 23.5x and peers' average of 21.7x, but below the broader U.S. Software industry average of 30.4x. This reflects investor confidence in its profitability and growth prospects, with earnings expected to grow nearly 10% annually. Risks include dependence on Chinese market demand and relatively rich valuation compared to peers. The stock trades just 0.9% below its intrinsic value according to discounted cash flow (DCF) estimates, suggesting near fair pricing.

Latest article

Mastercard Stock Jumps Before Earnings as Visa’s Big Beat Sends a Fresh Signal

Mastercard Stock Jumps Before Earnings as Visa’s Big Beat Sends a Fresh Signal

29 April 2026
Mastercard shares climbed 3.8% to $526.90 Wednesday after Visa beat profit estimates and raised its outlook, sending Visa shares up 8.7%. Mastercard reports first-quarter results Thursday. The company expanded its Start Path program this week to focus on business payments, with fintech Glass joining to work on public-sector procurement. Mastercard does not lend or issue cards, earning mainly from transaction fees.
GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

GE HealthCare Technologies Inc. Stock Sinks as Tariffs and Chip Costs Force Profit Cut

29 April 2026
GE HealthCare cut its 2026 profit forecast Wednesday, citing higher chip, oil, and freight costs, as well as tariffs and a supplier issue. Shares fell nearly 13% to $59.75. First-quarter revenue rose 7.4% to $5.13 billion, but net income dropped to $389 million from $564 million a year earlier. The company also announced a reorganization, merging its Imaging and Advanced Visualization units.
Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

29 April 2026
The U.S. Commerce Department ordered Applied Materials, Lam Research, and KLA to halt some chip-tool shipments to China’s Hua Hong, Reuters reported. The move targets shipments linked to facilities believed capable of advanced chip production. Applied reported $2.10 billion in China revenue last quarter, or 30% of its total. Shares in Applied, Lam, and KLA traded lower after the news.
Compass Group share price slips again as AI fears linger after Q1 update
Previous Story

Compass Group share price slips again as AI fears linger after Q1 update

Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook
Next Story

Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook

Go toTop